The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
May 19th 2024
With agents like semaglutide and tirzepatide becoming household drug names, Peterson discusses the short-term future of incretin drug development.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
February is American Heart Month: Treat Your Heart Well
February 21st 2008When I mention the cardiac diet I follow in upbeat fashion, I am looking to portray the genuine feeling that I really enjoy eating healthy. The game â€" and both my wife and I admit, the triumph â€" is being able to make tasty meals that are, in all seriousness, good for the heart.
The Critical Role of Intra-Abdominal Adiposity in Cardiometabolic Risk
February 8th 2008Accumulating epidemiological, biological, and mechanistic evidence has shown that adipose tissue is an active endocrine and metabolic organ that plays a critical role in the development of cardiometabolic risk factors, diabetes, and cardiovascular disease.
Insights into the Mechanism and Treatment of AF and Other Arrhythmias
This abstract oral session featured several researchers who reviewed (quite quickly) the results of their studies, focused on such topics as spatiotemporal behavior of high dominant frequency, isoproterenol agents, mistakes in the use of amiodarone and anticoagulation management, and 3D transesophageal ultrasound. Highlights of these studies are provided below.